* Approved Cinqair for use with other asthma medicines for maintenance treatment of severe asthma in patients aged 18 years and older Further company coverage:
The post BRIEF-FDA approves using Cinqair with other asthma medicines for treating severe asthma appeared first on NASDAQ.